BioMD Genetics Inc.

BioMD Genetics Inc. is a Canadian innovation-driven company that provides human genetic testing solutions to business partners AND personal genetics service directly to consumers and through authorized retailers. We have been constantly innovating and using the best current practices and technologies of human genetics science to provide our clients and customers with the best possible experience. Our highly creative and qualified team, consisting of researchers, practitioners and bioinformatics, ensures that top-quality services are delivered to our clients and customers.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

KANE BIOTECH WELCOMES RENOWNED CANADIAN VETERINARIAN, DR. JEAN GAUVIN, AS CHIEF VETERINARY OFFICER

BioSpace | February 20, 2020

news image

Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced that it has appointed Jean Gauvin, DVM, as its Chief Veterinary Officer (“CVO”), effective immediately. In the newly-created position of CVO, Dr. Gauvin will serve as a liaison between Kane Biotech and industry, guide the K...

Read More

RESEARCH

TURTLETREE AND SOLAR BIOTECH ENTER STRATEGIC PARTNERSHIP

TurtleTree | August 16, 2021

news image

Solar Biotech, led by industrial biotech expert Alex Berlin, has become a significant piece of the puzzle for sustainable food tech companies taking products to market. TurtleTree knew from the beginning that one of the biggest challenges for food tech companies was developing the technologies required to scale up bio-manufacturing processes. TurtleTree is a biotech company based in Singapore and the US. The company is focused on providing access to the best nutrients in milk usin...

Read More

CELL AND GENE THERAPY

OCEAN GENOMICS AND GENINUS TEAM UP TO DEVELOP RNA-BASED BIOMARKERS AND ADVANCE RESEARCH.

Ocean Genomics, Geninus Inc | March 30, 2021

news image

Ocean Genomics (Pittsburgh, PA), a world chief in AI-based gene expression analysis and RNA biomarker development, and Geninus (Seoul, South Korea), a main full-administration genomics laboratory, report an essential association with the end goal of co-creating RNA-based biomarkers and propelling exploration and clinical applications with emergency clinic, scholastic and biotechnology customers. The two organizations will dispatch in Korea Ocean Genomics' high level AI-based t...

Read More

LESAFFRE AND RECOMBIA BIOSCIENCES ANNOUNCES STRATEGIC PARTNERSHIP TO ADVANCE INNOVATIVE GENE EDITING TECHNOLOGY

Recombia Biosciences | November 02, 2020

news image

Recombia Biosciences announces the launch of operations in Brisbane, California. The company aims to harness its proprietary genome editing technologies to accelerate the development of yeast for sustainable production of fermented ingredients. For the next few years Recombia and Lesaffre will be joining forces in the area of yeast strain development. With its partnership with Recombia, Lesaffre is investing in major pioneering technology. The ability to generate thousands of yeast strains in pa...

Read More
news image

KANE BIOTECH WELCOMES RENOWNED CANADIAN VETERINARIAN, DR. JEAN GAUVIN, AS CHIEF VETERINARY OFFICER

BioSpace | February 20, 2020

Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced that it has appointed Jean Gauvin, DVM, as its Chief Veterinary Officer (“CVO”), effective immediately. In the newly-created position of CVO, Dr. Gauvin will serve as a liaison between Kane Biotech and industry, guide the K...

Read More
news image

RESEARCH

TURTLETREE AND SOLAR BIOTECH ENTER STRATEGIC PARTNERSHIP

TurtleTree | August 16, 2021

Solar Biotech, led by industrial biotech expert Alex Berlin, has become a significant piece of the puzzle for sustainable food tech companies taking products to market. TurtleTree knew from the beginning that one of the biggest challenges for food tech companies was developing the technologies required to scale up bio-manufacturing processes. TurtleTree is a biotech company based in Singapore and the US. The company is focused on providing access to the best nutrients in milk usin...

Read More
news image

CELL AND GENE THERAPY

OCEAN GENOMICS AND GENINUS TEAM UP TO DEVELOP RNA-BASED BIOMARKERS AND ADVANCE RESEARCH.

Ocean Genomics, Geninus Inc | March 30, 2021

Ocean Genomics (Pittsburgh, PA), a world chief in AI-based gene expression analysis and RNA biomarker development, and Geninus (Seoul, South Korea), a main full-administration genomics laboratory, report an essential association with the end goal of co-creating RNA-based biomarkers and propelling exploration and clinical applications with emergency clinic, scholastic and biotechnology customers. The two organizations will dispatch in Korea Ocean Genomics' high level AI-based t...

Read More
news image

LESAFFRE AND RECOMBIA BIOSCIENCES ANNOUNCES STRATEGIC PARTNERSHIP TO ADVANCE INNOVATIVE GENE EDITING TECHNOLOGY

Recombia Biosciences | November 02, 2020

Recombia Biosciences announces the launch of operations in Brisbane, California. The company aims to harness its proprietary genome editing technologies to accelerate the development of yeast for sustainable production of fermented ingredients. For the next few years Recombia and Lesaffre will be joining forces in the area of yeast strain development. With its partnership with Recombia, Lesaffre is investing in major pioneering technology. The ability to generate thousands of yeast strains in pa...

Read More